S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
New York lawmakers pass $237 billion budget with policies to jump-start housing market
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
NASDAQ:CERT

Certara (CERT) Stock Price, News & Analysis

$15.93
-0.28 (-1.73%)
(As of 04/19/2024 ET)
Today's Range
$15.83
$16.35
50-Day Range
$15.93
$19.45
52-Week Range
$11.81
$24.96
Volume
610,374 shs
Average Volume
502,360 shs
Market Capitalization
$2.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.06

Certara MarketRank™ Stock Analysis

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
25.9% Upside
$20.06 Price Target
Short Interest
Bearish
5.20% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.73
Upright™ Environmental Score
News Sentiment
0.65mentions of Certara in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$405,095 Sold Last Quarter
Proj. Earnings Growth
20.69%
From $0.29 to $0.35 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.45 out of 5 stars

Medical Sector

96th out of 908 stocks

Prepackaged Software Industry

26th out of 200 stocks

CERT stock logo

About Certara Stock (NASDAQ:CERT)

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

CERT Stock Price History

CERT Stock News Headlines

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Certara (NASDAQ:CERT) Upgraded at KeyCorp
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
Decoding 4 Analyst Evaluations For Certara
CERT Apr 2024 22.500 call
Schrodinger Inc.
CERT Apr 2024 17.500 call
Q4 2023 Certara Inc Earnings Call
Certara Reports Fourth Quarter 2023 Financial Results
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)?
Certara Inc Ordinary Shares CERT
See More Headlines
Receive CERT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/21/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CERT
Fax
N/A
Employees
1,391
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.06
High Stock Price Target
$24.00
Low Stock Price Target
$15.50
Potential Upside/Downside
+25.9%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
11 Analysts

Profitability

Net Income
$-55,360,000.00
Pretax Margin
-15.56%

Debt

Sales & Book Value

Annual Sales
$354.34 million
Cash Flow
$0.95 per share
Book Value
$6.55 per share

Miscellaneous

Free Float
156,026,000
Market Cap
$2.55 billion
Optionable
Optionable
Beta
1.63
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives


CERT Stock Analysis - Frequently Asked Questions

Should I buy or sell Certara stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Certara in the last year. There are currently 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CERT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CERT, but not buy additional shares or sell existing shares.
View CERT analyst ratings
or view top-rated stocks.

What is Certara's stock price target for 2024?

11 Wall Street research analysts have issued 1-year price objectives for Certara's stock. Their CERT share price targets range from $15.50 to $24.00. On average, they anticipate the company's stock price to reach $20.06 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for CERT
or view top-rated stocks among Wall Street analysts.

How have CERT shares performed in 2024?

Certara's stock was trading at $17.59 at the beginning of the year. Since then, CERT shares have decreased by 9.4% and is now trading at $15.93.
View the best growth stocks for 2024 here
.

Are investors shorting Certara?

Certara saw a increase in short interest in March. As of March 31st, there was short interest totaling 5,670,000 shares, an increase of 7.4% from the March 15th total of 5,280,000 shares. Based on an average daily trading volume, of 550,800 shares, the days-to-cover ratio is presently 10.3 days. Currently, 5.2% of the company's stock are sold short.
View Certara's Short Interest
.

When is Certara's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our CERT earnings forecast
.

How can I listen to Certara's earnings call?

Certara will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Certara's earnings last quarter?

Certara, Inc. (NASDAQ:CERT) issued its quarterly earnings data on Thursday, February, 29th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by $0.04. The company earned $88.01 million during the quarter, compared to analyst estimates of $86.80 million. Certara had a positive trailing twelve-month return on equity of 4.33% and a negative net margin of 15.62%.

What guidance has Certara issued on next quarter's earnings?

Certara updated its FY 2024 earnings guidance on Thursday, February, 29th. The company provided earnings per share (EPS) guidance of 0.410-0.460 for the period, compared to the consensus EPS estimate of 0.480. The company issued revenue guidance of $385.0 million-$400.0 million, compared to the consensus revenue estimate of $364.0 million.

When did Certara IPO?

Certara (CERT) raised $500 million in an initial public offering on Friday, December 11th 2020. The company issued 24,400,000 shares at $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair served as the underwriters for the IPO.

Who are Certara's major shareholders?

Certara's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (3.07%), State of Alaska Department of Revenue (0.13%) and First Hawaiian Bank (0.02%). Insiders that own company stock include Avatar Parent LP Eqt, Craig R Rayner, Eran Broshy, James E Cashman III, Jieun W Choe, Justin Edge, Leif E Pedersen, Mason P Slaine, Matthew M Walsh, Michael Andrew Schemick, Patrick F Smith, Richard M Traynor, Robert Aspbury, Stephen M Mclean and William F Feehery.
View institutional ownership trends
.

How do I buy shares of Certara?

Shares of CERT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CERT) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners